BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17409409)

  • 1. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer.
    Gayther SA; Song H; Ramus SJ; Kjaer SK; Whittemore AS; Quaye L; Tyrer J; Shadforth D; Hogdall E; Hogdall C; Blaeker J; DiCioccio R; McGuire V; Webb PM; Beesley J; Green AC; Whiteman DC; ; Goodman MT; Lurie G; Carney ME; Modugno F; Ness RB; Edwards RP; Moysich KB; Goode EL; Couch FJ; Cunningham JM; Sellers TA; Wu AH; Pike MC; Iversen ES; Marks JR; Garcia-Closas M; Brinton L; Lissowska J; Peplonska B; Easton DF; Jacobs I; Ponder BA; Schildkraut J; Pearce CL; Chenevix-Trench G; Berchuck A; Pharoah PD;
    Cancer Res; 2007 Apr; 67(7):3027-35. PubMed ID: 17409409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
    Goode EL; Fridley BL; Vierkant RA; Cunningham JM; Phelan CM; Anderson S; Rider DN; White KL; Pankratz VS; Song H; Hogdall E; Kjaer SK; Whittemore AS; DiCioccio R; Ramus SJ; Gayther SA; Schildkraut JM; Pharaoh PP; Sellers TA
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):935-44. PubMed ID: 19258477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival.
    Song H; Hogdall E; Ramus SJ; Dicioccio RA; Hogdall C; Quaye L; McGuire V; Whittemore AS; Shah M; Greenberg D; Easton DF; Kjaer SK; Pharoah PD; Gayther SA
    Clin Cancer Res; 2008 Feb; 14(4):1090-5. PubMed ID: 18281541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.
    Driver KE; Song H; Lesueur F; Ahmed S; Barbosa-Morais NL; Tyrer JP; Ponder BA; Easton DF; Pharoah PD; Dunning AM;
    Carcinogenesis; 2008 Feb; 29(2):333-41. PubMed ID: 18174243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of cell cycle control genes influence the development of sporadic medullary thyroid carcinoma.
    Barbieri RB; Bufalo NE; Secolin R; Assumpção LV; Maciel RM; Cerutti JM; Ward LS
    Eur J Endocrinol; 2014 Dec; 171(6):761-7. PubMed ID: 25565272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort.
    Azzato EM; Driver KE; Lesueur F; Shah M; Greenberg D; Easton DF; Teschendorff AE; Caldas C; Caporaso NE; Pharoah PD
    Breast Cancer Res; 2008; 10(3):R47. PubMed ID: 18507837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common variants in RB1 gene and risk of invasive ovarian cancer.
    Song H; Ramus SJ; Shadforth D; Quaye L; Kjaer SK; Dicioccio RA; Dunning AM; Hogdall E; Hogdall C; Whittemore AS; McGuire V; Lesueur F; Easton DF; Jacobs IJ; Ponder BA; Gayther SA; Pharoah PD
    Cancer Res; 2006 Oct; 66(20):10220-6. PubMed ID: 17047088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer.
    Song H; Ramus SJ; Kjaer SK; Hogdall E; Dicioccio RA; Whittemore AS; McGuire V; Hogdall C; Jacobs IJ; Easton DF; Ponder BA; Dunning AM; Gayther SA; Pharoah PD
    PLoS One; 2007 Mar; 2(3):e268. PubMed ID: 17342202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Single nucleotide polymorphisms in cell cycle regulator p21 and p27 genes are associated with susceptibility to epithelial ovarian cancer].
    Jin X; Kang S; Wang N; Xing YP; Li Y
    Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):209-12. PubMed ID: 18788572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer.
    Ye Y; Yang H; Grossman HB; Dinney C; Wu X; Gu J
    Cancer; 2008 Jun; 112(11):2467-74. PubMed ID: 18361427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis.
    Cunningham JM; Vierkant RA; Sellers TA; Phelan C; Rider DN; Liebow M; Schildkraut J; Berchuck A; Couch FJ; Wang X; Fridley BL; ; Gentry-Maharaj A; Menon U; Hogdall E; Kjaer S; Whittemore A; DiCioccio R; Song H; Gayther SA; Ramus SJ; Pharaoh PD; Goode EL
    Br J Cancer; 2009 Oct; 101(8):1461-8. PubMed ID: 19738611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of genetic polymorphisms in cell-cycle control genes and susceptibility to endometrial cancer among Chinese women.
    Cai H; Xiang YB; Qu S; Long J; Cai Q; Gao J; Zheng W; Shu XO
    Am J Epidemiol; 2011 Jun; 173(11):1263-71. PubMed ID: 21454826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of DNA repair and cell cycle control genes in ovarian cancer susceptibility.
    Mohamed FZ; Hussien YM; AlBakry MM; Mohamed RH; Said NM
    Mol Biol Rep; 2013 May; 40(5):3757-68. PubMed ID: 23277402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer.
    Quaye L; Song H; Ramus SJ; Gentry-Maharaj A; Høgdall E; DiCioccio RA; McGuire V; Wu AH; Van Den Berg DJ; Pike MC; Wozniak E; Doherty JA; Rossing MA; Ness RB; Moysich KB; Høgdall C; Blaakaer J; ; Easton DF; Ponder BA; Jacobs IJ; Menon U; Whittemore AS; Krüger-Kjaer S; Pearce CL; Pharoah PD; Gayther SA
    Br J Cancer; 2009 Mar; 100(6):993-1001. PubMed ID: 19240718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer.
    Quaye L; Tyrer J; Ramus SJ; Song H; Wozniak E; DiCioccio RA; McGuire V; Høgdall E; Høgdall C; Blaakaer J; Goode EL; Schildkraut JM; Easton DF; Krüger-Kjaer S; Whittemore AS; Gayther SA; Pharoah PD
    PLoS One; 2009 Jun; 4(6):e5983. PubMed ID: 19543528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate and related micronutrients, folate-metabolising genes and risk of ovarian cancer.
    Webb PM; Ibiebele TI; Hughes MC; Beesley J; van der Pols JC; Chen X; Nagle CM; Bain CJ; Chenevix-Trench G; ;
    Eur J Clin Nutr; 2011 Oct; 65(10):1133-40. PubMed ID: 21629268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer.
    Song H; Koessler T; Ahmed S; Ramus SJ; Kjaer SK; Dicioccio RA; Wozniak E; Hogdall E; Whittemore AS; McGuire V; Ponder BA; Turnbull C; Hines S; Rahman N; ; Eeles RA; Easton DF; Gayther SA; Dunning AM; Pharoah PD
    Cancer Res; 2008 Nov; 68(21):8837-42. PubMed ID: 18974127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in the promoter region of ESR2 gene and susceptibility to ovarian cancer.
    Schüler S; Lattrich C; Skrzypczak M; Fehm T; Ortmann O; Treeck O
    Gene; 2014 Aug; 546(2):283-7. PubMed ID: 24881814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STK15 polymorphisms and association with risk of invasive ovarian cancer.
    Dicioccio RA; Song H; Waterfall C; Kimura MT; Nagase H; McGuire V; Hogdall E; Shah MN; Luben RN; Easton DF; Jacobs IJ; Ponder BA; Whittemore AS; Gayther SA; Pharoah PD; Kruger-Kjaer S
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1589-94. PubMed ID: 15466974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants in telomere-maintenance genes are associated with ovarian cancer risk and outcome.
    Sun Y; Tao W; Huang M; Wu X; Gu J
    J Cell Mol Med; 2017 Mar; 21(3):510-518. PubMed ID: 28233473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.